Archive: 15/03/2021

Gilead, Merck team up to develop long-acting HIV drug

American pharmaceutical companies Gilead and Merck announced Monday they have partnered to develop a new HIV therapy that could see daily medications replaced by a treatment that can be taken at longer intervals.

Mar 15, 2021

0

23

How well do COVID vaccines protect after organ transplant?

A new study raised questions about how well COVID-19 vaccines protect organ transplant recipients—and what precautions people with suppressed immune systems should take after the shots.

Mar 15, 2021

0

24

Top Portugal court nixes euthanasia law, says it's imprecise

Portugal's Constitutional Court on Monday blocked a law passed by parliament introducing euthanasia and physician-assisted suicide for terminally ill and gravely injured people.

Mar 15, 2021

Oslo tightens up anti-Covid measures as cases rise

The Norwegian capital Oslo on Monday announced tougher measures to stem the spread of coronavirus, closing secondary schools and restricting the number of visitors to homes, as COVID case numbers rise.

Mar 15, 2021

0

1

Comparative adjuvant trial evaluates Army-developed ALF in HIV vaccine regimens

A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family ...

Mar 15, 2021

0

2

Criteria published for diagnosing the clinical syndrome of CTE during life

Newly published National Institute of Neurological Disorders and Stroke (NINDS) Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (TES) are the first expert consensus criteria developed for the clinical ...

Mar 15, 2021